A 52-year-old woman with history of glaucoma is brought to the ophthalmology clinic for routine follow-up. She has been using pilocarpine eye drops 2% four times daily for the past 3 years. On examination, she has significant miosis bilaterally, and visual acuity has declined from 20/20 to 20/40 over the past 6 months. Intraocular pressure (IOP) is well-controlled at 14 mmHg. The ophthalmologist suspects pilocarpine-induced cataract formation. What is the most appropriate next step in management?